来自MSN11 个月
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor ... or other smart device to continuously ...
Verywell Health on MSN10 个月
Dexcom vs. FreeStyle Libre: What to Know About These CGMs
Continuous glucose monitors (CGMs) are monitoring devices people with diabetes ... whereas only the FreeStyle Libre 2 system ...
pharmaphorum2 天
Lilly doubles down on Dexcom tech for connected insulin devices
Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Forbes1 年
The Holy Grail Of Health Monitoring Devices
But, had I been monitoring ... on a dedicated handheld device, Continuous Glucose Monitors (CGMs) have been growing steadily. Indeed, one of the leading CGM suppliers, Dexcom, sold its one ...
NBC Washington1 个月
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep ...
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Crain's Chicago Business28 天
Why Abbott and Dexcom buried the hatchet in their glucose monitor patent fight
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate ...